"10.1371_journal.pone.0088063","plos one","2014-02-10T00:00:00Z","Wei Qiao Qiu; Max Wallack; Michael Dean; Elizabeth Liebson; Mkaya Mwamburi; Haihao Zhu","Departments of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, United States of America; Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, United States of America; Alzheimers Disease Center, Boston University School of Medicine, Boston, Massachusetts, United States of America; McLean Hospital, Harvard Medical School, Belmont, Massachusetts, United States of America; Department of Public Health and Family Medicine, Tufts University, Boston, Massachusetts, United States of America","Conceived and designed the experiments: WQQ HZ. Performed the experiments: MW HZ. Analyzed the data: MD MM EL WQQ. Contributed reagents/materials/analysis tools: WQQ MM. Wrote the paper: WQQ MW EL.","The finding on amylin diagnosis and treatment for AD has been filed for the patent application. The patent is titled Compositions, Methods and Assays Comprising Amylin or Amylin Analogs for Abeta Peptide Mediated Disorders and numbered WO2013/151729 A1. However, the authors patent application does not alter the authors adherence to PLOS ONE policies on sharing data and material.","2014","02","Wei Qiao Qiu","WQQ",6,TRUE,2,2,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
